Could Low-Field MRI revolutionize brain disease detection?

NCT ID NCT06947876

Recruiting now Knowledge-focused Sponsor: University of Aberdeen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two new, cheaper MRI methods to see if they can spot brain changes caused by small vessel disease, a major cause of stroke and dementia. About 85 adults aged 50 and older with early signs of the disease will get scans using both standard and low-field MRI. The goal is to make brain imaging more affordable and widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL SMALL VESSEL DISEASE

Contacts and locations

Locations

AMT Center, Univeristy of Aberdeen
RECRUITING

Aberdeen, AB24 3FX, United Kingdom
Aberdeen Biomedical Imaging Centre, University of Aberdeen
RECRUITING

Aberdeen, AB24 3FX, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.